Biliary tree cancers

• Health & Medicine

Durvalumab immunotherapy recommended for advanced bile duct cancers in England and Scotland

The immunotherapy durvalumab (Imfinzi) is now available as a first treatment for advanced biliary tract cancers in England and Scotland. The immunotherapy durvalumab (Imfinzi) is now available as a first treatment for advanced biliary tract cancers in England and Scotland.

30 November 2023

• Health & Medicine

First treatment approved in England for advanced bile duct cancer

The National Institute of Health and Care Excellence (NICE) has approved the use of pemigatinib in adults with a rare type of bile duct cancer that has continued to advance or spread after initial chemotherapy. The National Institute of Health and Care Excellence (NICE) has approved the use of pemigatinib in adults with a rare type of bile duct cancer that has continued to advance or spread after initial chemotherapy.

22 July 2021

• Health & Medicine

‘A significant step forwards’ – treating patients with advanced biliary tract cancers

An existing combination of chemotherapy could be used to provide a new option for biliary tract cancer patients. An existing combination of chemotherapy could be used to provide a new option for biliary tract cancer patients.

30 March 2021

• Health & Medicine

Drug improves survival of patients with rare cancer by almost a quarter

Patients who take capecitabine after surgery for bile duct cancer live for almost a year and a half longer than those not given the drug. Patients who take capecitabine after surgery for bile duct cancer live for almost a year and a half longer than those not given the drug.

17 May 2017

• Health & Medicine

Trial results show dramatically improved survival for relapsed childhood leukaemia

A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia (ALL) returns. A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia (ALL) returns.

4 December 2010

• Health & Medicine

Making a impact in rarer cancers – the ABC02 trial

8 April 2010